Status:
UNKNOWN
Radiomics in Rectal Cancer
Lead Sponsor:
NHS Grampian
Collaborating Sponsors:
Industrial centre for Artificial intelligence Research
Roland Sutton Academic Trust
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective study aims to investigate whether initial imaging characteristics of rectal cancer on Magnetic Resonance Imaging (MRI) correlate with the underlying tumour pathology and oncological...
Detailed Description
Background Bowel cancer is the 4th most common type of cancer in the UK with 14,000 individuals diagnosed with rectal cancer each year. The management of rectal cancer has significantly changed in the...
Eligibility Criteria
Inclusion
- All patients with newly diagnosed rectal cancer within NHSG for the five year period (2010-2015) who had a pre-operative staging MRI at NHSG for whom pathology reported within NHSG.
Exclusion
- Those patients whose MRI scans are degraded from artifact (such as metal artifact from hip replacements)
- Patients lost to follow-up or moved out with NHS Grampian during follow-up.
- Patients with incomplete clinical or pathological data.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT05331040
Start Date
May 1 2020
End Date
May 1 2025
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS Grampian
Aberdeen, Aberdeenshire, United Kingdom, AB25 2ZN